Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2016, Article ID 5429316, 8 pages
http://dx.doi.org/10.1155/2016/5429316
Research Article

Factors Associated with Hormonal and Intrauterine Contraceptive Use among HIV-Infected Men and Women in Lilongwe, Malawi: A Cross-Sectional Study

1UNC Project-Malawi, Kamuzu Central Hospital, 100 Mzimba Road, Private Bag Box A-104, Lilongwe, Malawi
2University of North Carolina School of Medicine, Department of Obstetrics & Gynecology, University of North Carolina at Chapel Hill, 101 Manning Drive, CB No. 7570, Chapel Hill, NC 27599-7570, USA
3The Lighthouse Trust, Kamuzu Central Hospital, 100 Mzimba Road, Lilongwe, Malawi
4University of North Carolina School of Medicine, Department of Medicine, Chapel Hill, NC 27599-3368, USA
5The International Union against Tuberculosis and Lung Disease, 75006 Paris, France
6Emory University School of Medicine, Department of Gynecology and Obstetrics, Emory University, 49 Jesse Hill Jr. Drive, Atlanta, GA 30303, USA

Received 19 May 2016; Accepted 25 July 2016

Academic Editor: Maria Gallo

Copyright © 2016 Jennifer H. Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, WHO HIV/AIDS Fact Sheet, #360, World Health Organization, Geneva, Switzerland, 2015, http://www.who.int/mediacentre/factsheets/fs360/en/.
  2. UNAIDS, UNAIDS Malawi HIV/AIDS Estimates (2014), UNAIDS, Geneva, Switzerland, 2014, http://www.unaids.org/en/regionscountries/countries/malawi.
  3. National Statistical Office (NSO) and ICF Macro, Malawi Demographic and Health Survey 2010, NSO and ICF Macro, Zomba, Malawi, 2011.
  4. Ministry of Health, Clinical Management of HIV in Children and Adults, Ministry of Health, Malawi, Lilongwe, Malawi, 2011.
  5. National AIDS Commission, National HIV Prevention Strategy, 2015–2020, National AIDS Commission, Lilongwe, Malawi, 2014.
  6. L. Haddad, S. Phiri, C. Cwiak et al., “Fertility preferences, unintended pregnancy and contraceptive use among HIV-positive women desiring family planning in Lilongwe, Malawi,” Contraception, vol. 84, no. 3, p. 325, 2011. View at Publisher · View at Google Scholar
  7. W. Muyindike, R. Fatch, R. Steinfield et al., “Contraceptive use and associated factors among women enrolling into HIV care in southwestern Uganda,” Infectious Diseases in Obstetrics and Gynecology, vol. 2012, Article ID 340782, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Chibwesha, M. S. Li, C. K. Matoba et al., “Modern contraceptive and dual method use among HIV-infected women in Lusaka, Zambia,” Infectious Diseases in Obstetrics and Gynecology, vol. 2011, Article ID 261453, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. A. Melaku and E. G. Zeleke, “Contraceptive utilization and associated factors among HIV positive women on chronic follow up care in tigray region, northern ethiopia: a cross sectional study,” PLoS ONE, vol. 9, no. 4, Article ID e94682, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. B. Polis, R. H. Gray, T. Lutalo et al., “Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994–2006,” Contraception, vol. 83, no. 6, pp. 549–555, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Polisi, E. Gebrehanna, G. Tesfaye, and F. Asefa, “Modern contraceptive utilization among female ART attendees in health facilities of Gimbie town, West Ethiopia,” Reproductive Health, vol. 11, no. 1, article 30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. H. M. Asfaw and F. E. Gashe, “Contraceptive use and method preference among HIV positive women in Addis Ababa, Ethiopia: a cross sectional survey,” BMC Public Health, vol. 14, no. 1, article 566, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. I. Nieves, A. Kaida, G. R. Seage et al., “The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda,” Contraception, vol. 92, no. 2, pp. 152–159, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Andia, A. Kaida, M. Maier et al., “Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda,” American Journal of Public Health, vol. 99, no. 2, pp. 340–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kaida, F. Laher, S. A. Strathdee et al., “Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services,” PLoS ONE, vol. 5, no. 11, Article ID e13868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D. O. Laryea, Y. A. Amoako, K. Spangenberg, E. Frimpong, and J. Kyei-Ansong, “Contraceptive use and unmet need for family planning among HIV positive women on antiretroviral therapy in Kumasi, Ghana,” BMC Women's Health, vol. 14, no. 1, article 126, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. C. Ezugwu, P. O. Nkwo, P. U. Agu, E. O. Ugwu, and A. O. Asogwa, “Contraceptive use among HIV-positive women in Enugu, southeast Nigeria,” International Journal of Gynecology & Obstetrics, vol. 126, no. 1, pp. 14–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. World Health Organization, Department of Reproductive Health and Research (WHO/RHR), Johns Hopkins Bloomberg School of Public Health, and Center for Communication Programs (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2011 update), CCP and WHO, Baltimore, Md, USA, 2011.
  19. S. Phiri, C. Feldacker, T. Chaweza et al., “Integrating reproductive health services into HIV care: strategies for successful implementation in a lowresource HIV clinic in Lilongwe, Malawi,” Journal of Family Planning and Reproductive Health Care, vol. 42, no. 1, pp. 17–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Y. Zou, “A modified poisson regression approach to prospective studies with binary data,” American Journal of Epidemiology, vol. 159, no. 7, pp. 702–706, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. M. S. Coutinho, M. Scazufca, and P. R. Menezes, “Methods for estimating prevalence ratios in cross-sectional studies,” Revista de Saúde Pública, vol. 42, no. 6, pp. 1–6, 2008. View at Google Scholar
  22. F. E. Harrell, Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis, Springer, New York, NY, USA, 2001.
  23. World Health Organization, Medical Eligibility Criteria, WHO, Geneva, Switzerland, 5th edition, 2015.
  24. S. H. Perry, P. Swamy, G. A. Preidis, A. Mwanyumba, N. Motsa, and H. N. Sarero, “Implementing the Jadelle implant for women living with HIV in a resource-limited setting: concerns for drug interactions leading to unintended pregnancies,” AIDS, vol. 28, no. 5, pp. 791–793, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Pyra, R. Heffron, N. R. Mugo et al., “Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy,” AIDS, vol. 29, no. 17, pp. 2353–2359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. R. C. Patel, M. Onono, M. Gandhi et al., “Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study,” The Lancet HIV, vol. 2, no. 11, pp. e474–e482, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. K. K. Scarsi, K. M. Darin, S. Nakalema et al., “Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation over 48 weeks,” Clinical Infectious Diseases, vol. 62, no. 6, pp. 675–682, 2016. View at Publisher · View at Google Scholar